Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants With Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Lp(a)FRONTIERS EXPANSION Study
Schedule
Notes
Credits
Heart Theater 2‚ Science and Technology Hall‚ South Hall‚ Heart Hub
K. Ferdinand{1}, F. Rodriguez{2}, D. Baldari{3}, j. sullivan{4}, A. Gutierrez{5}, S. Venkataraman{6}, K. Onate Quiroz{7}, H. Cao{8}, W. Zhu{9}, J. Wang{10}, M. D. Shapiro{11}; {1}Tulane SOM, New Orleans, LA, {2}Standford University, Palo Alto, CA, {3}Cardiology Partners, West Palm Beach, FL, {4}Grandview Medical Center-Birmingham, Birmingham, AL, {5}Inpatient Research Clinic LLC, Miami Lakes, FL, {6}Novartis Pharmaceuticals, Southlake, TX, {7}Novartis Pharmaceuticals, New York, NY, {8}Novartis, Princeton, NJ, {9}Novartis Pharmaceuticals UK Ltd., London, United Kingdom, {10}Novartis Pharmaceuticals, East Hanover, NJ, {11}Wake Forest Univ School of Medicine, Winston Salem, NC
